Medicine Description xigduo 5/1000mg
xigduo 5/1000mg tablets is a medication that combines Dapagliflozin and Metformin to effectively manage blood glucose levels in adults with type 2 diabetes. Dapagliflozin is a sodium-glucose co-transporter 2 (SGLT2) inhibitor that works by preventing the reabsorption of glucose by the kidneys, leading to increased glucose excretion in urine. This reduction in blood glucose levels reduces the burden on insulin production. Metformin, on the other hand, primarily decreases hepatic glucose production and enhances insulin sensitivity in peripheral tissues. Together, these actions result in improved glycemic control and mitigate the risks associated with type 2 diabetes.
Indications and Uses of xigduo 5/1000mg tablets
- Management of type 2 diabetes mellitus as an adjunct to diet and exercise
- Used in patients where metformin alone does not provide adequate glycemic control
- May be beneficial for weight management in overweight patients
Side Effects of xigduo 5/1000mg tablets
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Increased risk of urinary tract infections
- Potential for lactic acidosis
Storage and Handling
Store xigduo 5/1000mg tablets at room temperature, away from moisture and heat. Keep out of reach of children. Do not use past the expiration date on the package.
Patient Advice and Precautions
Patients should be counselled on the importance of adherence to a prescribed diet and regular physical activity to optimize the medication's efficacy. Monitor blood sugar levels regularly. Inform healthcare providers of any unusual symptoms or side effects, particularly those indicating lactic acidosis such as unusual muscle pain, difficulty breathing, or unusual tiredness.